Leading physicians are condemning the UK's decision to allow patients to buy a cholesterol–lowering statin drug without prescriptions as a colossal “experiment.” In May, the UK declassified Simvastatin (Zocor), a statin, as an over-the-counter pharmaceutical, following advice from its